MED15 and nonpapillary renal cell carcinoma: MED15 knockdown in ccRCC inhibited the expression of key SREBP-dependent lipid biosynthesis enzymes (FASN, ACC1, ACLY, and SCD1), which subsequently led to a decrease in lipid accumulation.